How the Medical Device Regulation (MDR) Affects Dental Distributors in Europe

MDR Overview and Transition Timeline

The MDR (EU) 2017/745 has applied since 26 May 2021, replacing the former directives. To avoid disruption, transitional provisions permitted some MDD-certified “legacy” devices to remain on the market; Regulation (EU) 2023/607 extended those timelines (to 2027/2028, depending on class) and removed the 2025 sell-off date. Regardless, distributors must already follow MDR duties when making devices available.

Key MDR Obligations for Dental Distributors (Article 14)

Pre-market checks — verify before supplying:

• CE mark & EU Declaration of Conformity: Confirm the device bears CE marking and that the manufacturer has drawn up an EU Declaration of Conformity. Do not release products lacking these.

• Labelling and IFU in local language(s): Verify labels/IFU are present and provided in the official language(s) of the destination country.

• Importer identification (if applicable): For non-EU products, check that the EU importer is identified on the label/packaging/accompanying document.

• UDI present where required: Confirm that a UDI has been assigned and is on the label/packaging according to the applicable timeline.

During distribution — keep devices compliant:

• Storage & transport: Store and ship per manufacturer specifications so device performance/safety are not compromised.

• Do not supply non-conforming/suspect devices: If a device is non-compliant, falsified, expired, or poses a serious risk, withhold it, inform the manufacturer (and AR/importer as relevant), and notify authorities when a serious risk or falsification is suspected.

• Cooperate with FSCA/recalls: Support corrective actions, withdrawals, or recalls by contacting customers and coordinating returns/replacements.

Post-market duties — vigilance & PMS:

• Complaints and incident handling: Keep a register of complaints, suspected incidents, non-conformities, and recalls/withdrawals. Immediately forward complaints/incident information to the manufacturer (and AR/importer where applicable).

• Provide documentation to authorities: Upon request, provide information you hold that is necessary to demonstrate device conformity; cooperate with inspections and requests for samples.

Traceability and UDI

• Identify your upstream and downstream partners: Be able to name who supplied each device to you and who you supplied it to (e.g., dental practices/labs).

• Retention periods: Keep distribution records for at least 10 years after the last device was supplied (15 years for implantables).

• UDI lists for certain devices: Maintain UDI information for Class III implantable devices you receive or supply. Using electronic systems with barcode scanning is strongly recommended for all device classes.

Documentation & Practical Implementation

• Incoming inspection SOP: Use a standardized checklist for CE mark, DoC, labels (language), importer details, UDI presence, packaging integrity, expiry dates.

• Complaints/recall register: Log issues with dates, device ID (UDI/lot/serial), actions taken, and communications sent.

• Document access: Keep or be able to promptly obtain Declarations of Conformity and relevant certificates from manufacturers.

• Training: Train warehouse, sales, and customer-service teams on MDR checks, storage requirements, complaint intake, and escalation.

• Internal audits: Periodically review process compliance with Article 14 and refine SOPs.

• Article 16 caution (repackaging/relabeling): Avoid altering packaging/IFU unless necessary; if you do, Article 16 triggers QMS certification and prior notifications.

Conclusion

The MDR elevates the role of dental distributors as a critical compliance checkpoint and a core part of post-market safety. By embedding checklists, traceability systems, vigilance processes, and robust documentation, distributors protect patients and practices, and meet their legal obligations.

Disclaimer & Methodology

This article was prepared from primary EU legal texts and official guidance (MDR 2017/745, EU Commission, and MDCG documents). It is general information, not legal advice. Always consult the latest official publications and your legal counsel for decisions affecting compliance.

Sources

1. Regulation (EU) 2017/745 (MDR) – EUR-Lex: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32017R0745

2. EC Guidance for Distributors & Importers (2019) – PDF: https://health.ec.europa.eu/system/files/2021-10/md_mdr_distributors_importers_en_0.pdf

3. MDCG 2021-27 Rev.1 (2023) – Q&A on Importers/Distributors: https://health.ec.europa.eu/system/files/2023-03/mdcg_2021-27_rev1_en_0.pdf

4. MDCG 2021-26 (2021) – Article 16 (Relabeling/Repackaging): https://health.ec.europa.eu/system/files/2021-10/mdcg_2021-26_en_0.pdf

5. Regulation (EU) 2023/607 – MDR Transitional Amendment: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32023R0607

6. EC MDR Transition Q&A / Factsheets (legacy devices & obligations): https://health.ec.europa.eu/comitology/medical-devices-new-regulations_en